Among the differentially methylated genes was hypermethylation of the promoter for miR-219, a miRNA that has been linked to breast cancer development and has been identified as a potential regulator of circadian duration via the modulation of CLOCK- and BMAL1-dependent Per transcription [146, 154, 155]. The gene discussed is CLOCK; the disease is breast carcinoma.